BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sollelis E, Quinard RM, Bouguen G, Goutte M, Goutorbe F, Bouvier D, Pereira B, Bommelaer G, Buisson A. Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease. World J Gastroenterol 2019; 25(19): 2354-2364 [PMID: 31148906 DOI: 10.3748/wjg.v25.i19.2354]
URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2354.htm
Number Citing Articles
1
Gabriele Dragoni, Tommaso Innocenti, Andrea Galli. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?Digestive Diseases 2021; 39(3): 190 doi: 10.1159/000511641
2
Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang, Hua-Guo Xu. Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-AnalysisJournal of Clinical Medicine 2023; 12(3): 1206 doi: 10.3390/jcm12031206
3
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor, Sue Mallett. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic reviewHealth Technology Assessment 2021; 25(45): 1 doi: 10.3310/hta25450
4
Changchang Ge, Zhaofeng Shen, Yi Lu, Xiaojuan Liu, Yiheng Tong, Mengyuan Zhang, Yijing Liu, Hong Shen, Lei Zhu. Propensity score analysis the clinical characteristics of active distal and extensive ulcerative colitis: a retrospective studyFrontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1136659
5
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem Bemelman, Silvio Danese, Jean Yves Mary, David Rubin, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Iris Dotan, Maria T. Abreu, Axel Dignass. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology 2021; 160(5): 1570 doi: 10.1053/j.gastro.2020.12.031
6
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitisScandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
7
Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Eirini Theodoraki, Ioannis E. Koutroubakis. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel DiseaseJournal of Clinical Medicine 2023; 12(7): 2452 doi: 10.3390/jcm12072452
8
Nikolas Plevris, Charlie W. Lees. Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and PossibilitiesGastroenterology 2022; 162(5): 1456 doi: 10.1053/j.gastro.2022.01.024
9
T. Kucharzik, B. Verstockt, C. Maaser. Monitoring of patients with active inflammatory bowel diseaseFrontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1172318
10
Lorant Gonczi, Talat Bessissow, Peter Laszlo Lakatos. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?World Journal of Gastroenterology 2019; 25(41): 6172-6189 doi: 10.3748/wjg.v25.i41.6172
11
Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel DiseaseLife 2021; 11(12): 1375 doi: 10.3390/life11121375
12
Maté Gergely, Parakkal Deepak. Tools for the Diagnosis and Management of Crohn's DiseaseGastroenterology Clinics of North America 2022; 51(2): 213 doi: 10.1016/j.gtc.2021.12.003